Skip to main content
. Author manuscript; available in PMC: 2016 Feb 27.
Published in final edited form as: Biochem Biophys Res Commun. 2015 Jan 29;458(1):214–219. doi: 10.1016/j.bbrc.2015.01.093

Fig. 1. Effect of GSNO treatment on pathological tau phosphorylation in primary cultured neurons treated with Aβ25–35.

Fig. 1

A. The primary cultured cortical neurons were pretreated with 100µM of GSNO for 4 hrs and treated with Aβ25–35 (40µM) for 12 hrs and neuronal levels of phosphorylated tau (Ser396, Ser404, and Ser202/Thr205), total tau, and β-actin (loading control) were analyzed by Western blot analysis. B. The effects of GSNO metabolites and other S-nitrosothiol donor on Aβ25–35-induced tau phosphorylation (Ser396), cultured neurons were pretreated with GSNO, aged or decomposed GSNO (agGSNO), sodium nitrate (NaNO3), sodium nitrite (NaNO2), or S-nitroso-N-acetylpenicillamine (SNAP) for 4hrs and treated with Aβ25–35 (40µM).